Friday, September 24, 2010

The FDA restricts use of diabetes drug Avandia

The Food and Drug Administration announced Thursday that access to the diabetes drug Avandia will be restricted to patients with Type 2 diabetes whose condition cannot be controlled with other medications.

The drug has been linked to increased risks of cardiovascular events, such as heart attack and stroke, in patients taking the drug.

Also Thursday, the European Medicines Agency recommended that Avandia be taken off the market. The EMA is Europe’s counterpart to the U.S. Food and Drug Administration (FDA), and is responsible for the approval of all drugs and medical devices sold in Europe. This decision must be ratified by the European Commission before going into effect.

No comments:

Post a Comment